Eventide Asset Management - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$355,000
+6.6%
400,0000.0%0.01%
-20.0%
Q4 2018$333,000
-2.1%
400,0000.0%0.02%
+25.0%
Q3 2018$340,000
-12.6%
400,0000.0%0.01%
-25.0%
Q2 2018$389,000
+6.3%
400,0000.0%0.02%
-5.9%
Q1 2018$366,000
+7.3%
400,0000.0%0.02%
-5.6%
Q4 2017$341,000
-6.1%
400,0000.0%0.02%
-14.3%
Q3 2017$363,000
+5.2%
400,0000.0%0.02%0.0%
Q2 2017$345,000400,0000.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 3,586,000$3,237,0002.17%
Telemetry Investments, L.L.C. 4,000,000$3,610,0001.29%
Castle Creek Arbitrage, LLC 6,000,000$5,419,0000.54%
Man Investments (CH) AG 600,000$542,0000.46%
SSI INVESTMENT MANAGEMENT LLC 5,683,000$5,129,0000.44%
CANYON CAPITAL ADVISORS LLC 29,000,000$26,173,0000.39%
PFM Health Sciences, LP 21,362,000$19,386,0000.38%
IRON Financial LLC 500,000$454,0000.35%
Partner Investment Management, L.P. 373,000$338,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 29,555,000$26,667,0000.30%
View complete list of ACORDA THERAPEUTICS INC shareholders